Druker Brian 4
4 · AMGEN INC · Filed May 21, 2026
Research Summary
AI-generated summary of this filing
Amgen (AMGN) Director Brian Druker Receives 665 RSUs
What Happened
Brian Druker, a director of Amgen Inc. (AMGN), was granted/received 665 restricted stock units (RSUs) on 2026-05-19. The filing shows an acquisition at $0.00 (award), meaning these were compensation awards rather than cash purchases. The RSUs vested immediately and are payable one-for-one in Amgen common stock; the filing reports the award value as $0.
Key Details
- Transaction date: 2026-05-19; Form 4 filed 2026-05-21 (timely filing).
- Transaction type/code: A (award/grant/acquisition); price reported $0.00.
- Shares acquired: 665 RSUs (total).
- Of the 665, 408 are dividend equivalents (DEs) credited to unvested RSUs under the plan (see footnote).
- Vested RSUs are paid in shares on a one-to-one basis and may be deferred by the director per an elected deferral schedule.
- Shares owned after the transaction: not specified in the provided excerpt.
- This appears to be routine director compensation, not an open-market purchase or sale.
Context
- RSU awards to directors are common as part of board compensation; they don’t necessarily signal a personal market view.
- Dividend equivalents (DEs) are additional credits tied to dividends that are ultimately paid out as shares per the RSU terms.
- Because the award vested immediately, Druker will receive (or has received) shares unless he elected to defer payment under Amgen’s deferral rules.
Insider Transaction Report
Form 4
AMGEN INCAMGN
Druker Brian
Director
Transactions
- Award
Common Stock
[F1][F2]2026-05-19+665→ 8,391 total
Footnotes (2)
- [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.
- [F2]These shares include 408 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Signature
/s/ Brian J. Druker|2026-05-19